Cramer’s lightning round: Editas Medicine is not a buy

DraftKings Inc: “They are in a battle, a pure battle to try to get market share and right now, there is no sign that the battle is over. … I do think they’ll win.”

SoFi Technologies Inc: “I can’t tell you to sell it. But I can also tell you, maybe I’m not the answer on this stock because holy cow, it hasn’t stopped [going down in price] and I thought it would have.”

Editas Medicine Inc: “You can not buy growth stocks that have no hope of making money. Not in this environment.”

Altria Group Inc: “It is tobacco, and that’s not what I’m fond of. … If you don’t care, then it’s fine.”

Source

Business

Investors are making up the highest share of homebuyers in 5 years

October 7, 2025

A sold sign is posted in front of a home for sale on Aug. 27, 2025 in San Francisco, California. Justin Sullivan | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals […]

Business

Inside Alts: How Ares is capitalizing on the ‘retail revolution’ in alternative assets

October 7, 2025

A version of this article appeared in CNBC’s Inside Alts newsletter, a guide to the fast-growing world of alternative investments, from private equity and private credit to hedge funds and venture capital. Sign up to receive future editions, straight to your inbox. At Ares Management’s analyst day last month, the alternative asset manager quietly bumped up its […]

Business

Constellation Brands reiterates lower full-year guidance

October 6, 2025

Modelo beer is displayed on a shelf at a Safeway store on Oct. 6, 2025 in San Anselmo, California. Justin Sullivan | Getty Images Modelo owner Constellation Brands beat on the top and bottom lines in its fiscal second-quarter earnings report on Monday and reiterated its lowered full-year guidance due to macroeconomic headwinds. Shares of […]